Literature DB >> 11860472

Temporally controlled targeted somatic mutagenesis in the mouse brain.

P Weber1, D Metzger, P Chambon.   

Abstract

To develop spatio-temporally controlled somatic mutagenesis in the adult mouse nervous system, we established transgenic mice expressing the tamoxifen-inducible Cre-ERT recombinase under the control of the mouse prion protein (PrP) promoter. Cre-ERT was expressed in most regions of the brain and in the retina of one transgenic line, whereas its expression was mostly restricted to the hippocampus and the cerebellum in another line. As tamoxifen efficiently induced Cre-mediated recombination in the various neuronal cell types expressing Cre-ERT in the brain of adult mice, the PrP-Cre-ERT lines should be valuable tools to study the functions of genes involved in neurodegenerative diseases or regeneration, and in complex processes such as behaviour, learning and memory. Some limitations of presently available reporter lines for Cre-mediated recombination in adult mouse CNS are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11860472     DOI: 10.1046/j.0953-816x.2001.01803.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  23 in total

Review 1.  Orchestrating transcriptional control of adult neurogenesis.

Authors:  Jenny Hsieh
Journal:  Genes Dev       Date:  2012-05-15       Impact factor: 11.361

Review 2.  Pancreatic cell lineage analyses in mice.

Authors:  Pedro L Herrera; Virginie Nepote; Alexandra Delacour
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

3.  In vivo reprogramming of astrocytes to neuroblasts in the adult brain.

Authors:  Wenze Niu; Tong Zang; Yuhua Zou; Sanhua Fang; Derek K Smith; Robert Bachoo; Chun-Li Zhang
Journal:  Nat Cell Biol       Date:  2013-09-22       Impact factor: 28.824

4.  Ischemic stroke injury is mediated by aberrant Cdk5.

Authors:  Douglas A Meyer; Melissa I Torres-Altoro; Zhenjun Tan; Alessandro Tozzi; Massimiliano Di Filippo; Vincent DiNapoli; Florian Plattner; Janice W Kansy; Stanley A Benkovic; Jason D Huber; Diane B Miller; Paul Greengard; Paolo Calabresi; Charles L Rosen; James A Bibb
Journal:  J Neurosci       Date:  2014-06-11       Impact factor: 6.167

5.  Forebrain-specific deletion of Cdk5 in pyramidal neurons results in mania-like behavior and cognitive impairment.

Authors:  Susan C Su; Andrii Rudenko; Sukhee Cho; Li-Huei Tsai
Journal:  Neurobiol Learn Mem       Date:  2013-07-11       Impact factor: 2.877

Review 6.  Gene-targeting technologies for the study of neurological disorders.

Authors:  Vassilios Beglopoulos; Jie Shen
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

7.  Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.

Authors:  William J Meilandt; Moustapha Cisse; Kaitlyn Ho; Tiffany Wu; Luke A Esposito; Kimberly Scearce-Levie; Irene H Cheng; Gui-Qiu Yu; Lennart Mucke
Journal:  J Neurosci       Date:  2009-02-18       Impact factor: 6.167

8.  Regulation of hippocampal and behavioral excitability by cyclin-dependent kinase 5.

Authors:  Ammar H Hawasli; Della Koovakkattu; Kanehiro Hayashi; Anne E Anderson; Craig M Powell; Christopher M Sinton; James A Bibb; Donald C Cooper
Journal:  PLoS One       Date:  2009-06-04       Impact factor: 3.240

9.  Inducible gene manipulations in serotonergic neurons.

Authors:  Tillmann Weber; Gerald Böhm; Elke Hermann; Günther Schütz; Kai Schönig; Dusan Bartsch
Journal:  Front Mol Neurosci       Date:  2009-11-06       Impact factor: 5.639

10.  Split-CreERT2: temporal control of DNA recombination mediated by split-Cre protein fragment complementation.

Authors:  Johannes Hirrlinger; Robert P Requardt; Ulrike Winkler; Franziska Wilhelm; Christine Schulze; Petra G Hirrlinger
Journal:  PLoS One       Date:  2009-12-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.